「国创上头条」既有CD47,又有PD-L1,盘点最新5款获授权引进中国的创新药( 三 )
[3]信达生物与Alector达成合作 在中国开发和商业化抗SIRP-alpha抗体. Retrieved March 26 , 2020, from https://www.prnasia.com/story/275928-1.shtml
[4]Laekna Acquires Exclusive Global Rights to Clinical-Stage Cancer Asset. Retrieved March 24 , 2020, from https://www.businesswire.com/news/home/20200324005279/en/Laekna-Acquires-Exclusive-Global-Rights-Clinical-Stage-Cancer?from=singlemessage&isappinstalled=0
【「国创上头条」既有CD47,又有PD-L1,盘点最新5款获授权引进中国的创新药】[5]Tarveda Therapeutics and SciClone Pharmaceuticals International Establish Licensing Agreement for PEN-866 in Greater China. Retrieved Mar 19 2020 from https://www.tarvedatx.com/3-19-20-tarveda-therapeutics-and-sciclone-pharmaceuticals-international-establish-licensing-agreement-for-pen-866-in-greater-china
- 医院头条31岁男子,饭后常打嗝,查出胃癌,医生痛斥:怎能拿它当饭吃
- 『离职』头条员工吐槽:绩效差被HR劝退,果断拒绝!结果HR的话让他蒙了
- 丁香健康头条母亲节到底能送啥啊
- 榴莲雪糕妈妈的厨艺
- 东方头条向往的生活4,包烧鸡脚筋是啥菜?黄小厨教你如何做这道菜
- 东方头条唐艺昕孕期发泳装照,四肢纤细状态良好,张若昀亲制孕妇餐
- 白酒既有历史底蕴又有独特气质,怪不得最近一款酒开始流行
- 【东方头条】“马来西亚周杰伦”Jordan上热搜!一身肌肉火爆ins
- 『头条女神』哪些部位会更容易受基因影响呢?看了佟丽娅和她姐姐,我们明白了
- 「东方头条」等了2年,这部9.4分国产顶级片回归就爆了